SCHEMBL17437338

SCHEMBL17437338

CCn1c(-n2ncnc2N)nc2cncc(-c3cccc(NC(C)=O)c3)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4K2A Q9BTU6 1/20 0.41
MAP4K4 O95819 1/20 0.40
FYN P06241 4/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
STAT1 P42224 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
BRAF P15056 3/20 0.39
USP7 Q93009 2/20 0.39
ATR Q13535 2/20 0.39
ROCK1 Q13464 1/20 0.38
RET P07949 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
CHEK2 O96017 1/20 0.38
CSNK2A1 P68400 1/20 0.38
POLB P06746 1/20 0.37
MCL1 Q07820 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437344 0.82 ADORA3 (0.36) NPC1TP53STAT1RAB9ASMN1; SMN2
SCHEMBL17437393 0.80 ADORA2A (0.39) NPC1RAB9ASMN1; SMN2ADORA2AADORA1
SCHEMBL17437366 0.78 DHFR (0.36) ADORA1
SCHEMBL17437397 0.77 GRIN2B (0.32)
SCHEMBL16054588 0.77 RPS6KA5 (0.37) ROCK1
SCHEMBL17437441 0.77 NPC1 (0.32) NPC1RAB9ASMN1; SMN2USP7PIK3CD
SCHEMBL17437427 0.76 TLR7 (0.33)
SCHEMBL17437551 0.76 POLB (0.36) NPC1RAB9ASMN1; SMN2POLB
SCHEMBL17437331 0.75 PIK3CA (0.36) ROCK1PIK3CD
SCHEMBL17437453 0.75 RPS6KA5 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 PI4K2A 307/4885MAP4K4 1321/4885FYN 1169/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 PI4K2A 307/4885MAP4K4 1321/4885FYN 1169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.